HFA Premium Access

Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial

Congress Presentation

About the speaker

Doctor Alberto Foa'

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
0 follower

3 more presentations in this session

Analysis of the PARAGON-HF study results using win ratio

Speaker: Doctor W. Kim (Seoul, KR)

Thumbnail

Feasibility, efficacity and safety of a fast up-titration program of heart failure treatments in real-life practice.

Speaker: Miss L. Blasi (Toulouse, FR)

Thumbnail

Real-world impact of early quadruple therapy in HFrEF: a comparative analysis of sequential vs. simultaneous approaches

Speaker: Mr D. Ferreira (Lisbon, PT)

Thumbnail

Access the full session

Chronic heart failure - treatment 3

Speakers: Doctor A. Foa', Doctor W. Kim, Miss L. Blasi, Mr D. Ferreira
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations